Revolution Medicines' average one-year price target was raised to €116.43 per share from €104.36, an 11.57% increase. The update is based on averaged analyst targets and signals improving external expectations rather than new operating results. The article is informational and likely has only a modest stock impact.
Revolution Medicines' average one-year price target was raised to €116.43 per share from €104.36, an 11.57% increase. The update is based on averaged analyst targets and signals improving external expectations rather than new operating results. The article is informational and likely has only a modest stock impact.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.20
Ticker Sentiment
